MyoGene Bio receives a Translational Research Program grant from the California Institute for Regenerative Medicine

December 15, 2021

MyoGene Bio has received a $3.4M grant from the California Institute for Regenerative Medicine to advance preclinical development of our gene editing therapy for Duchenne. We are greatly appreciative of their support! 

Read more here: 

https://magnify.cnsi.ucla.edu/2021/12/16/december-15-2021-gene-therapy-start-up-secures-3-4-million-award-from-california-stem-cell-agency/

 and here:

https://www.uclahealth.org/news/article/gene-editing-duchenne-muscular-dystrophy